Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer
Clinical trial NCT01625429 · UNKNOWN
Trial details
- NCT number
- NCT01625429
- Sponsor
- Shanghai Cancer Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.